SAGE logo

Sage Therapeutics, Inc. (SAGE)

Profile

Full Name

Sage Therapeutics, Inc.

Ticker

NASDAQ: SAGE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 18, 2014

Indexes

Not included

Website

https://www.sagerx.com

Employees

353

Key Details

Price

$8.68

Market cap

$544.94M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$41.24M(-52.30% YoY)

Annual EPS

-$6.59(+27.18% YoY)

PE ratio

-

Next earnings date

Oct 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.68
    SAGE price is $8.68

    30-Day Relative Volume

    0.00
    SAGE 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    -
    SAGE price change on Jul 31, 2025 is unknown

    Price YTD change

    +59.85%
    SAGE price is up +59.85% since January 1st

    Price 1-year change

    +5.98%
    SAGE price is up +5.98% year-on-year

    Price 3-year change

    -79.26%
    SAGE price is down -79.26% over the past 3 years

    Price Range

    Price All-time high

    $195.97
    SAGE price is currently -95.57% below its historical high of $195.97

    Price 3-year low

    $4.62
    SAGE price is currently +87.88% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $544.94M
    SAGE market capitalization is $544.94 million

    Market cap 3-year change

    -78.09%
    SAGE market capitalization is down -78.09% over the past 3 years

    Market cap All-time high

    $9.78B
    SAGE market capitalization is currently -94.43% below its historical high of $9.78 billion

    Market cap sector rank

    -
    SAGE market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.84%
    SAGE shares outstanding is up +2.84% year-on-year

    Shares Outstanding 3-Year Change

    +5.65%
    SAGE shares outstanding is up +5.65% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.08
    SAGE beta is 1.08

    200-day SMA

    $7.15
    SAGE price is currently +21.32% above its 200-day simple moving average

    50-day SMA

    $8.20
    SAGE price is currently +5.82% above its 50-day simple moving average

    RSI

    46.56
    SAGE 14-day relative strength index is 46.56

    Volume

    0.00
    SAGE 30-day relative volume is 0.00

    ATR

    $0.04
    SAGE average true range is $0.04

    10-day Historical Volatility

    14.08%
    SAGE 10-day historical volatility is 14.08%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $41.24M
    SAGE annual revenue is $41.24 million

    Revenue Analysts estimate

    $98.07M
    SAGE annual revenue is currently -57.95% lower than the consensus analysts' forecast

    Revenue 1-year change

    -52.3%
    SAGE annual revenue is down -52.3% year-on-year

    Revenue Sector rank

    -
    SAGE annual revenue is unknown

    EPS

    EPS

    -$6.59
    SAGE annual earnings per share is -$6.59

    EPS Analysts estimate

    -$3.61
    SAGE annual earnings per share is currently +82.55% higher than the consensus analysts' forecast

    EPS 1-year change

    +27.18%
    SAGE annual earnings per share is up +27.18% year-on-year

    EPS Sector rank

    -
    SAGE annual earnings per share is unknown

    Profit

    Gross profit

    $30.77M
    SAGE annual gross profit is $30.77 million

    Gross margin

    74.60%
    SAGE annual gross profit margin is 74.60%

    Operating profit

    -$410.52M
    SAGE annual operating income is -$410.52 million

    Operating margin

    -995.36%
    SAGE annual operating profit margin is -995.36%

    Net income

    -$400.67M
    SAGE annual net profit is -$400.67 million

    Net margin

    -971.48%
    SAGE annual net profit margin is -971.48%

    Expenses

    Total expenses

    $451.76M
    SAGE annual total expenses is $451.76 million

    Operating expenses

    $442.31M
    SAGE annual total operating expenses is $442.31 million

    Cost of goods sold

    $10.47M
    SAGE annual cost of goods sold is $10.47 million

    Selling, general & administrative expenses

    $216.42M
    SAGE annual SGA is $216.42 million

    Depreciation and amortization

    $1.03M
    SAGE annual depreciation & amortization is $1.03 million

    Interest expense

    $0.00
    SAGE annual interest expense is $0.00

    Income tax

    $0.00
    SAGE annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$410.52M
    SAGE annual earnings before interest & taxes is -$410.52 million

    EBITDA

    -$409.49M
    SAGE annual EBITDA is -$409.49 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $547.22M
    SAGE annual total assets is $547.22 million

    Non current assets

    $15.92M
    SAGE annual long term assets is $15.92 million

    Current assets

    $531.30M
    SAGE annual total current assets is $531.30 million

    Cash and cash equivalents

    $81.02M
    SAGE annual cash & cash equivalents is $81.02 million

    Accounts receivable

    $9.13M
    SAGE annual accounts receivable is $9.13 million

    Inventory

    $0.00
    SAGE annual inventory is $0.00

    Liabilities

    Total liabilities

    $82.13M
    SAGE annual total liabilities is $82.13 million

    Long term liabilities

    $10.52M
    SAGE annual total long term liabilities is $10.52 million

    Current liabilities

    $71.61M
    SAGE annual total current liabilities is $71.61 million

    Accounts payable

    $12.70M
    SAGE annual accounts payable is $12.70 million

    Debt

    Total debt

    $11.84M
    SAGE annual total debt is $11.84 million

    Total debt 1-year change

    +129.16%
    SAGE annual total debt is up +129.16% year-on-year

    Long term debt

    $10.52M
    SAGE annual long term debt is $10.52 million

    Short term debt

    $1.32M
    SAGE annual short term debt is $1.32 million

    Equity & Capital

    Shareholders equity

    $465.09M
    SAGE annual stockholders equity is $465.09 million

    Book value

    $465.09M
    SAGE annual book value is $465.09 million

    Retained earnings

    -$2.97B
    SAGE annual retained earnings is -$2.97 billion

    Working capital

    $459.69M
    SAGE annual working capital is $459.69 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$267.19M
    SAGE annual cash flow from operations is -$267.19 million

    Cash from operations 1-year change

    +50.57%
    SAGE annual cash flow from operations is up +50.57% year-on-year

    Cash from investing

    $266.68M
    SAGE annual cash flow from investing activities is $266.68 million

    Cash from investing 1-year change

    -39.79%
    SAGE annual cash flow from investing activities is down -39.79% year-on-year

    Cash from financing

    $10.66M
    SAGE annual cash flow from financing activities is $10.66 million

    Cash from financing 1-year change

    +76.92%
    SAGE annual cash flow from financing activities is up +76.92% year-on-year

    CAPEX

    CAPEX

    $0.00
    SAGE annual capital expenditures is $0.00

    CAPEX 1-year change

    -100%
    SAGE annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free cash flow

    -$267.19M
    SAGE annual free cash flow is -$267.19 million

    Free cash flow 1-year change

    +50.62%
    SAGE annual free cash flow is up +50.62% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    74.60%
    SAGE annual gross profit margin is 74.60%

    Operating margin

    -995.36%
    SAGE annual operating profit margin is -995.36%

    Net margin

    -971.48%
    SAGE annual net profit margin is -971.48%

    ROA & ROE

    ROA

    -56.06%
    SAGE annual return on assets is -56.06%

    ROE

    -63.37%
    SAGE annual return on equity is -63.37%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SAGE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SAGE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.48
    SAGE price to book ratio is 1.48

    PB ratio Sector rank

    -
    SAGE price to book ratio is unknown

    PS Ratio

    PS ratio

    7.74
    SAGE price to sales ratio is 7.74

    PS ratio Sector rank

    -
    SAGE price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $190.79M
    SAGE enterprise value is $190.79 million

    Enterprise value Sector rank

    -
    SAGE enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -0.63
    SAGE EV/EBITDA is -0.63

    EV/EBITDA Sector rank

    -
    SAGE EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.42
    SAGE annual current ratio is 7.42

    Quick ratio

    7.42
    SAGE annual quick ratio is 7.42

    Leverage

    Debt to equity

    0.03
    SAGE annual debt to equity ratio is 0.03

    Interest coverage ratio

    -
    SAGE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    SAGE piotroski f-score value is unknown

    Altman Z-Score

    -5.01
    SAGE altman z-score is -5.01

    Analyst ratings

    Recent major analysts updates

    Jul 8, 25 Scotiabank
    Sector Perform
    Jun 20, 25 Baird
    Neutral
    Jun 17, 25 Truist Securities
    Hold
    Jun 17, 25 Piper Sandler
    Neutral
    Jun 17, 25 HC Wainwright & Co.
    Neutral
    Jun 17, 25 Canaccord Genuity
    Hold
    Jun 16, 25 Needham
    Hold
    Apr 30, 25 Needham
    Hold
    Apr 25, 25 Needham
    Hold
    Feb 12, 25 Wedbush
    Neutral

    Institutional Ownership

    Screeners with SAGE included

    Stocks with high beta
    Best performing stocks last 3 months
    Stocks above SMA 50
    Stocks above analysts price target
    Best performing stocks YTD
    Stocks above SMA 200
    • What is the ticker symbol for Sage Therapeutics, Inc.?
    • Does Sage Therapeutics, Inc. pay dividends?
    • What sector is Sage Therapeutics, Inc. in?
    • What industry is Sage Therapeutics, Inc. in?
    • What country is Sage Therapeutics, Inc. based in?
    • When did Sage Therapeutics, Inc. go public?
    • Is Sage Therapeutics, Inc. in the S&P 500?
    • Is Sage Therapeutics, Inc. in the NASDAQ 100?
    • Is Sage Therapeutics, Inc. in the Dow Jones?
    • When was Sage Therapeutics, Inc.'s last earnings report?
    • When does Sage Therapeutics, Inc. report earnings?

    What is the ticker symbol for Sage Therapeutics, Inc.?

    The ticker symbol for Sage Therapeutics, Inc. is NASDAQ:SAGE

    Does Sage Therapeutics, Inc. pay dividends?

    No, Sage Therapeutics, Inc. does not pay dividends

    What sector is Sage Therapeutics, Inc. in?

    Sage Therapeutics, Inc. is in the Healthcare sector

    What industry is Sage Therapeutics, Inc. in?

    Sage Therapeutics, Inc. is in the Biotechnology industry

    What country is Sage Therapeutics, Inc. based in?

    Sage Therapeutics, Inc. is headquartered in United States

    When did Sage Therapeutics, Inc. go public?

    Sage Therapeutics, Inc.'s initial public offering (IPO) was on July 18, 2014

    Is Sage Therapeutics, Inc. in the S&P 500?

    No, Sage Therapeutics, Inc. is not included in the S&P 500 index

    Is Sage Therapeutics, Inc. in the NASDAQ 100?

    No, Sage Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Sage Therapeutics, Inc. in the Dow Jones?

    No, Sage Therapeutics, Inc. is not included in the Dow Jones index

    When was Sage Therapeutics, Inc.'s last earnings report?

    Sage Therapeutics, Inc.'s most recent earnings report was on July 30, 2025

    When does Sage Therapeutics, Inc. report earnings?

    The next expected earnings date for Sage Therapeutics, Inc. is October 29, 2025
    On this page